Viracta Therapeutics, Inc.
Q4 2017 13F Holders
Symbol
VIRX
CUSIP
867328700
Type
Equity
Class
COM PAR
Num filings
46
Total reported value, excl. options
$67.2 M
Compare 2017 Q4 to
2020 Q4
2020 Q3
2020 Q2
2020 Q1
2019 Q4
2019 Q3
2019 Q2
2019 Q1
2018 Q4
2018 Q3
2018 Q2
2018 Q1
2017 Q3
2017 Q2
2017 Q1
2016 Q4
2016 Q3
Manager
Report Date
Value ($000)
Shares
Option Type